Samsung Biologics acquires drug product manufacturing approval from U.S. FDA

Published: 2018-08-03 16:30:00
Updated: 2018-08-06 09:32:26

Samsung Biologics(CEO Tae-Han Kim) announced on the 25th that they acquired manufacturing approval of its first finished drug product from the Food and Drug Administration, a federal agency of the United States Department of Health and Human Services.

Previously, the company acquired product app...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.